Table 2. Ribotype distribution among community-associated vs. hospital-acquired CDIs, stratified by age <65.
| Ribotype | Community-onset, n (%) | Hospital-onset, n (%) | ||||
|---|---|---|---|---|---|---|
| Total†
n = 2618 |
Age <65 n = 1177 |
Age ≥65 n = 1238 |
Total‡
n = 1259 |
Age <65 n = 621 |
Age ≥65 n = 627 |
|
| 014–020 | 445 (17.0) | 235 (20.0) | 182 (14.7) | 218 (17.3) | 110 (17.7) | 106 (16.9) |
| 027 | 427 (16.3) | 128 (10.9) | 278 (22.5) | 200 (15.9) | 82 (13.2) | 116 (18.5) |
| 106 | 316 (12.1) | 145 (12.3) | 137 (11.1) | 167 (13.3) | 78 (15.6) | 86 (13.7) |
| 002 | 255 (9.7) | 120 (10.2) | 110 (8.9) | 105 (8.3) | 47 (7.6) | 57 (9.1) |
| 255 | 108 (4.1) | 54 (4.6) | 51 (4.1) | 41 (3.3) | 27 (4.3) | 14 (2.2) |
| 001 | 86 (3.3) | 43 (3.7) | 35 (2.8) | 62 (4.9) | 34 (5.5) | 27 (4.3) |
| 054 | 67 (2.6) | 29 (2.5) | 31 (2.5) | 42 (3.3) | 25 (4.0) | 16 (2.6) |
| 078–126 | 74 (2.8) | 35 (3.0) | 38 (3.1) | 27 (2.1) | 17 (2.7) | 10 (15.9) |
| 053–163 | 52 (2.0) | 17 (1.4) | 32 (2.6) | 35 (2.8) | 13 (2.1) | 22 (3.5) |
| 017 | 57 (2.2) | 32 (2.7) | 19 (1.5) | 28 (2.2) | 19 (3.1) | 9 (1.4) |
| All others | 731 (27.9) | 339 (28.8) | 325 (26.3) | 334 (26.5) | 169 (27.2) | 164 (26.2) |
†203 patients missing age information, ‡11 missing age information.